On the occasion of the World Antibiotic Awareness Week (WAAW), BEAM Alliance has published a series of comics illustrating behind the scenes impressions of…
BEAM Alliance is among the partners of AMR-focused incubator INCATE. We spoke with Marc Gitzinger, CEO of BioVersys and Vice-President of the BEAM Alliance…
Together with the International Development Research Center (IDRC), the Global AMR R&D Hub published a new report analysing the funding patterns of animal health…
The Boehringer Ingelheim Venture Fund is among the industry partners of AMR-focused incubator INCATE. We spoke with investment manager Philipp Müller who is part…
The Japanese pharma company Shionogi is among the industry partners of AMR-focused incubator INCATE. We spoke with infectious disease expert Hideki Maki who represents…
BioNTech SE has acquired PhagoMed GmbH, an Austrian start-up for precision antimicrobial treatments supported by the European Institute of Innovation and Technology (EIT). PhagoMed…
In mid-November, the AMR community welcomed the official introduction of Cures 2.0 by the bipartisan team of U.S. Reps. Diana DeGette (D-CO) and Fred Upton (R-MI).…
A new European consortia called PrIMAVeRA is developing an open-source, web-based platform combining mathematical models with an epidemiological repository to inform decision makers about…
Antibiotic Research UK (ANTRUK) announced that through its 2021 Small Research Grants / Career Development Awards programme it will support seven new research projects…